Concord Biotech Limited has informed the Exchange about Schedule of meet
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech has scheduled an earnings call with investors and analysts on Monday, 11th August 2025 at 4:00 PM IST, hosted by Centrum Broking. The call will discuss the unaudited standalone and consolidated financial results for Q1FY26 (quarter ended 30th June 2025) and future outlook. Senior management including Chairman & MD Sudhir Vaid, Joint MD & CEO Ankur Vaid, CFO Lalit Sethi, and AVP Accounts & Finance Prakash Sajnani will participate. The invite includes dial-in numbers for domestic and international participants.
This is a routine disclosure informing the market about an upcoming investor call ahead of Q1FY26 results. No direct impact on stock price is expected from the invite itself, but it signals continued investor engagement and upcoming earnings disclosure.